Dr Lal PathLabs: Dr. Lal PathLabs Limited Reports Earnings Results for the Full Year Ended March 31, 2025

Dr. Lal PathLabs Limited reported earnings results for the full year ended March 31, 2025. For the full year, the company reported sales was INR 24,614 million compared to INR 22,266 million a year ago. Revenue was INR 25,548 million compared to INR 22,958 million a year ago. Net income was INR 4,871 million compared to INR 3,577 million a year ago. Basic earnings per share from continuing operations was INR 58.48 compared to INR 43.05 a year ago. Diluted earnings per share from continuing operations was INR 58.4 compared to INR 42.98 a year ago. Dr. Lal PathLabs Limited reported earnings results for the full year ended March 31, 2025. For the full year, the company reported sales was INR 24,614 million compared to INR 22,266 million a year ago. Revenue was INR 25,548 million compared to INR 22,958 million a year ago. Net income was INR 4,871 million compared to INR 3,577 million a year ago. Basic earnings per share from continuing operations was INR 58.48 compared to INR 43.05 a year ago. Diluted earnings per share from continuing operations was INR 58.4 compared to INR 42.98 a year ago.